Catalog Advanced Search
172 Results
-
Annual, virtual conference covering sepsis-related topics and offering RN CE Contact Hours
Description
Sepsis Alliance Summit returns for a 6th year this September! This free, virtual 2-day conference features insightful, innovative presentations from a diverse group of experts, including clinicians, researchers, innovators, and key leaders in the field.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve sepsis care. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
-
Includes a Live Web Event on 08/20/2025 at 11:00 AM (PDT)Cytovale Sponsored Webinar: Transforming Sepsis Care: A Nurse-Led Revolution at St. Dominic Hospital
Content provided by Cytovale (No CE credits offered)
Webinar Description:
In this sponsored webinar, discover how IntelliSep is helping redefine sepsis care in the ED by providing a fast, objective, and reliable diagnostic solution that supports early decision-making. Learn how the nursing team at St. Dominic Hospital transformed sepsis response using IntelliSep, leading to greater diagnostic clarity, smoother team communication, improved patient outcomes, and streamlined workflows. Finally, hear a real-world story about a Nurse Practitioner at St. Dominic's who survived sepsis, and how her experience reshaped her clinical practice.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Cytovale for this sponsored webinar.
Rhonda Collins, DNP, RN, FAAn
Chief Nursing Officer
Cytovale
Rhonda Collins, DNP, RN, FAAN, is the Chief Nursing Officer at Cytovale and a leader in healthcare innovation. A nurse for over 30 years, she co-founded the American Nurse Project to elevate nurses’ voices.
Previously, she served as Chief Nursing Officer at Vocera, improving clinical communication worldwide. She also held leadership roles at CareFusion, Masimo, and Fresenius Kabi, where she led a medical device through FDA clearance and U.S. launch.
A Fellow of the American Academy of Nursing, Dr. Collins holds degrees from Texas Tech University Health Sciences Center and the University of Texas. A published author and sought-after speaker, she focuses on nursing leadership, cognitive overload, and communication technology in healthcare.
Tracey Smithson, RN, MSN, NEA-BC
Chief Nursing Officer
St. Dominic’s Medical Center
Tracey Smithson, RN, MSN, NEA-BC, is an accomplished healthcare executive with over three decades of clinical and leadership experience. As Vice President and Chief Nursing Officer at St. Dominic’s Medical Center, she provides strategic and clinical oversight for a multi-campus system encompassing 5,000 staff and 565 beds, including a comprehensive stroke center, a level III trauma emergency department, and the Mississippi Heart & Vascular Institute.
Tracey has a proven track record of improving clinical outcomes, streamlining operations, and leading major accreditations and redesignations across multiple facilities. She is a sought-after speaker and thought leader, recognized as one of Dallas-Fort Worth’s Great 100 Nurses and a Leader of the Year at Medical City North Hills. Tracey serves on the board of the Mississippi Heart and Vascular Institute and remains an active voice in advancing nursing excellence and healthcare delivery across the Southeast.
Dan Woods, MSN, RN
Senior Director of Emergency Services and Hospital Throughput
St. Dominic’s Medical Center
Dan Woods, MSN, RN, is a dynamic healthcare executive with clinical roots and a decade of progressive leadership experience. As Senior Director of Emergency Services and Hospital Throughput for St. Dominic Health within Franciscan Missionaries of Our Lady Health System, he leads patient flow and acute care transfer strategies across a multi-hospital network serving thousands of patients across the Gulf South.
Dan has led enterprise initiatives including the development of centralized transfer and logistics centers, large-scale ED expansions, community crises, and EHR transitions, all aimed at improving throughput, resource utilization, and care delivery across the continuum. His work is grounded in data, frontline collaboration, and real-time operational responsiveness.
A frequent speaker on operational excellence, he has been honored as the Catholic Health Association’s Tomorrow’s Leader and one of Mississippi’s Emerging Leaders. Committed to developing future talent, Dan mentors through the ACHE mentoring program and serves on the board of the Greater Jackson Chamber of Commerce, helping shape the future of care delivery and workforce development.
-
Includes Multiple Live Events. The next is on 07/16/2025 at 8:00 AM (PDT)
Join us for a viewing party that will broadcast all five modules of our new program, Sepsis Alliance Presents: Sepsis Fundamentals!
Description:
Date: Wednesday, July 16, 2025
Time: 11:00 am - 3:15 pm ET / 8:00 am - 12:15 pm PT
You're Invited: Sepsis Fundamentals Viewing Party!
Join us for a special viewing party as we showcase all five modules of our brand-new program, Sepsis Alliance Presents: Sepsis Fundamentals.
Sepsis is still the leading cause of death in U.S. hospitals, and early recognition and treatment can make all the difference. That’s why sepsis education is more important than ever. Research shows that targeted training helps healthcare professionals recognize the signs of sepsis sooner and respond more effectively—ultimately saving lives.
Sepsis Fundamentals is a comprehensive, multi-part course created for nurses, sepsis coordinators, and other healthcare professionals. It’s designed to build a strong foundation in essential sepsis knowledge and serves as a stepping stone to more advanced training.
We hope you’ll join us for this opportunity to learn, connect, and strengthen your sepsis response skills—together.
Modules in the Program:
- Sepsis Epidemiology
- Sepsis Recognition
- Sepsis Diagnosis, Treatment, and Monitoring
- Sepsis Recovery
- Sepsis Quality Improvement and Patient Safety
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the epidemiology of sepsis, including its prevalence, risk factors, and impact on patient outcomes;
- Recognize the early signs and symptoms of sepsis across different patient populations using clinical assessment tools;
- Differentiate sepsis from other conditions by interpreting diagnostic criteria, laboratory findings, and clinical presentations;
- Implement evidence-based treatment protocols for sepsis management, including fluid resuscitation, antimicrobial therapy, and supportive care;
- Support patient recovery by identifying post-sepsis syndrome symptoms and recommending appropriate follow-up care and rehabilitation strategies;
- Evaluate strategies for sepsis quality improvement and patient safety, including protocol adherence, early warning systems, and multidisciplinary teamwork.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges Baxter for their support for the Sepsis Fundamentals program.
Chanu Rhee, MD, MPH, FIDSA
Assistant Professor of Population Medicine
Harvard Pilgrim Health Care Institute / Harvard Medical School
Chanu Rhee, MD, MPH, is an Associate Professor of Population Medicine at Harvard Medical School and an infectious disease and critical care physician at Brigham and Women's Hospital. He is internationally recognized for his contributions and expertise in the epidemiology, surveillance, diagnosis, prevention, and management of sepsis and infections in critically ill patients. He conducts clinical and epidemiologic research with a particular focus on harnessing electronic health record data to generate insights that advance clinical practice, quality improvement, public health strategy, and healthcare policy. He has been a leader in sepsis quality improvement efforts within the Mass General Brigham system and has participated in many national committees focused on improving sepsis care and outcomes, including in his current role as Chair of the Infectious Diseases Society of America’s Sepsis Advisory Panel. Dr. Rhee is an associate editor for Clinical Infectious Diseases, a member of the editorial boards for Critical Care Medicine and Critical Care Explorations, and a Fellow of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, and the American College of Critical Care Medicine.
Christa A. Schorr, DNP, MSN, RN, NEA-BC, FCCM
Professor of Medicine; Clinical Nurse Scientist
Cooper Medical School at Rowan University; Cooper University Hospital
Christa Schorr, DNP, MSN, RN, RCCM, NEA-BC, is a Clinical Nurse Scientist at Cooper University Hospital and a Professor of Medicine at Cooper Medical School at Rowan University. During her 30+ years in nursing, she has practiced clinically, directed critical care quality improvement and clinical research, and served as the Program Manager for a North American sepsis clinical trial. Dr. Schorr received her Diploma in Nursing from Helene Fuld School of Nursing, Bachelor of Science in Nursing from Thomas Jefferson University, and her Masters of Science in Nursing and Doctorate of Nursing Practice degrees from Drexel University.
Dr. Schorr has lectured nationally and internationally and has authored or co-authored over 90 peer-reviewed articles and book chapters. She served as national faculty for the Phase III and IV Society of Critical Care Medicine Surviving Sepsis Campaign (SSC) Collaboratives and three statewide collaboratives and is a co-investigator for the NHLBI-sponsored Assessment of Implementation Methods in Sepsis and Respiratory Failure (AIMS) trial.
Dr. Schorr is a member of the SSC Steering Committee and was the 2021 SSC Guidelines Committee Group Head for the long-term outcomes and goals of care section. In 2021, Dr. Schorr received the prestigious Asmund S. Laerdal Memorial Award in conjunction with the 50th annual Critical Care Congress. She stresses the importance of early sepsis identification, and the significance of patient and family engagement in her work.
Laura Evans, MD, MSc
Professor, Division of Pulmonary, Critical Care, and Sleep Medicine; Medical Director, Critical Care
University of Washington Medical Center
Laura Evans, MD, MSc, is a professor of medicine at the University of Washington and the Medical Director of Critical Care at the University of Washington Medical Center. Her interests focus on sepsis and preparedness for high-consequence infectious diseases, particularly on guideline development and implementation, as well as patient safety/quality improvement.
Dr. Evans earned her medical degree at the University of Michigan and did her residency in internal medicine at Columbia University. She completed pulmonary and critical care medicine fellowship training and earned a Master of Science in epidemiology at the University of Washington. She then joined the New York University and Bellevue Hospital faculty in 2006. In her role there, she led the evacuation of the Bellevue Hospital intensive care units in the aftermath of Hurricane Sandy. She was the clinical lead for New York City’s only patient with Ebola. She was associate program director for the pulmonary and critical care fellowship program at NYU for more than 10 years. After 14 years in NYC, she returned to Seattle in 2019.
She joined the steering committee of the Surviving Sepsis Campaign (SSC) in 2012 and was the co-chair of the past two revisions of the SSC adult sepsis guidelines and SSC COVID management guidelines co-chair. She also served as the critical care team lead for the National Institutes of Health COVID Management Guidelines. She is the current chair of the American Board of Internal Medicine’s Critical Care Medicine specialty board.
Stephanie Taylor, MD, MS
Professor of Internal Medicine; Chief, Division of Hospital Medicine
University of Michigan
Stephanie Taylor, MD, MS, focuses her research on improving patient outcomes and developing innovative practices to promote optimal care for sepsis patients in both early antibiotic management and post-discharge transition and recovery. She employs her expertise in health services research, pragmatic trials, large datasets, and implementation science to identify and address essential healthcare questions related to quality, value, and equity of care. Dr. Taylor is also the Division Chief of Hospital Medicine at Michigan Medicine.
Hallie Prescott, MD, MSc
Associate Professor
University of Michigan
Hallie Prescott, MD, MSc, is an Associate Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She is an expert in long-term outcomes and recovery after sepsis. Her research program has been funded by AHRQ, NIH, and Department of Veterans Affairs. She is a vice-chair of the Surviving Sepsis Campaign guidelines, council member of the International Sepsis Forum, and physician-lead for a BlueCross/Blue Shield of Michigan sepsis quality improvement consortium of 50 Michigan hospitals.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 4.3 contact hours.
Other healthcare professionals will receive a certificate of attendance for 3.5 contact hours.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Register for this if you plan to claim CE credits for 3+ podcast episodes.
Description:
This package includes the CE evaluations and CE credits for each individual podcast episode. You can register for the individual episode evaluations if you plan to complete fewer than three.
Forget everything you ever read in a textbook when it comes to antimicrobial resistance (AMR) and sepsis complications – because they rarely play by the rules. They evolve, adapt, and strike before it’s too late. While classic symptoms like fever, tachycardia, and hypotension are well known, the real challenge lies in recognizing the unexpected to reduce your mental list of those unknown, unknowns.
Hosted by Critical Care RN & CNS Author Nicole Kupchik, The Sepsis Spectrum is an exploration of real-world patient cases, expert insights, and clinical deep dives to unravel the most complex presentations facing modern medicine. Through gripping stories and in-depth interviews, Nicole examines diagnostic challenges, cutting-edge treatments, and the growing threat of AMR.
Designed for healthcare professionals at every level, The Sepsis Spectrum is about leaving you with more than compelling stories—it’s a vital resource in podcast form. Whether you’re at the bedside or in the classroom, you’ll finish each episode with practical, life-saving knowledge—and earn free CE Contact Hours for nurses along the way.
The fight against sepsis and AMR starts with recognition — because the most dangerous threats are the ones you don’t see coming.
Learning Objectives:
At the end of the series, the learner should be able to:
- Identify the public health threat posed by antimicrobial resistance (AMR) and describe the relationship between infection prevention, AMR, and sepsis;
- Assess the interconnections between humans, animals, and the environment in relation to AMR and sepsis;
- Apply recommendations for recognizing, diagnosing, and treating AMR and sepsis in outpatient and pre-hospital settings;
- Analyze the consequences of healthcare-acquired infections involving multi-drug-resistant organisms and discuss strategies for their prevention;
- Describe the importance of multi-disciplinary collaboration among infection prevention, antimicrobial stewardship, and sepsis teams in enhancing early detection, appropriate treatment, and improved outcomes in infectious disease management;
- Explore innovations in AMR and sepsis diagnostics and treatments, with a focus on how they aim to personalize patient care;
- Evaluate how quality improvement and patient safety practices address healthcare-acquired infections, multidrug-resistant organisms, and sepsis;
- Implement best practices for care coordination and transitions of care discharge planning, with an emphasis on AMR and antimicrobial stewardship in post-sepsis patient care;
- Consider specific care needs and best practices for managing AMR and sepsis in specialty populations, including pediatric, maternal, and immunocompromised patients.
Target audience:
All healthcare professionals and healthcare students including nurses, physicians, advanced practice providers, pharmacists, infectious disease and prevention specialists, scientists, and researchers, sepsis coordinators, sepsis data & quality professionals, healthcare executives and leadership, nursing and medical school deans & faculty, professional healthcare organizations, healthcare advocates, government, and industry.
-
Content provided by FIZE Medical (No CE credits offered)
Webinar Description:
Join top critical care experts in this FIZE Medical-sponsored webinar for a fresh look at managing unstable ICU patients using available biomarkers and real-time metrics. This webinar will cover the latest on sepsis, acute kidney injury (AKI), and hemodynamic management. Attendees will leave with a better understanding of how smarter data can drive faster, more targeted decisions when every second counts in the ICU.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by FIZE Medical for this sponsored webinar.
Joseph Carcillo, MD
Professor of Critical Care Medicine and Pediatrics
University of Pittsburgh, Department of Critical Care Medicine
Joseph Carcillo, MD, specializes in pediatric critical care medicine and pediatrics. He is certified by the American Board of Pediatrics and affiliated with UPMC Horizon, UPMC Mercy, UPMC Children's Hospital of Pittsburgh, UPMC Altoona, and UPMC Northwest. He completed his medical degree at George Washington University Medical Center, along with a residency and fellowship at Children's National Medical Center. He was previously Taskforce Chair of the ACCM Guidelines for Hemodynamic Support of Newborn and Pediatric Septic Shock, and a member of the Centers for Disease Control and Prevention (CDC) Taskforce for Definitions of Pediatric Sepsis.
Ravindra L. Mehta, MD, FACP, FRCP
Program Director - Associate Chair for Clinical Medicine, Department of Medicine
UC San Diego School of Medicine
Ravindra Mehta, MD, FACP, FRCP, is a Professor Emeritus of Medicine at the University of California San Diego where he directs the UCSD Master of Advanced Studies in Clinical Research program and is the site Principal Investigator of the NIH-funded UAB/UCSD O’Brien Center for AKI research. He chairs the annual International AKI and CRRT Conference in San Diego. Dr. Mehta is a founding member of the Acute Dialysis Quality Initiative (ADQI) and the Acute Kidney Injury Network (AKIN). His research has informed >span class="NormalTextRun SCXW217165272 BCX0"> development of the KDIGO guidelines for AKI. He has spearheaded several innovative multicenter studies on AKI including the International Society of Nephrology (ISN) AKI 0by25 project.
In 2008 Dr. Mehta was recognized by the American Nephrologists of Indian Origin and in March 2009 he was elected as a Fellow of the Royal College of Physicians in the UK. He received the ISN Bywaters Award for lifetime achievement in AKI in 2011 and in 2020 the ISN honored him by establishing a fellowship in AKI in his name.
He received the M.B.B.S. degree (1976) from the Government Medical School in Amritsar, India, and the M.D. (1979) and D.M. (1981) degrees from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He obtained his boards in Internal Medicine (1986) and Nephrology (1988) at the University of Rochester in Rochester New York. He has been on the faculty at UC San Diego since 1988.
-
This session explores the most severe forms of sepsis affecting pregnant and postpartum individuals in the U.S.
Description:
Date: May 14, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Maternal Sepsis Week highlights the urgency of addressing perinatal sepsis, a leading cause of maternal morbidity and mortality. This session explores the most severe forms of sepsis affecting pregnant and postpartum individuals in the U.S., examining their connection to emerging infectious threats. Current treatment guidelines will be applied to critical care scenarios, assessing the effectiveness of different management strategies. The session also focuses on proactive approaches to early detection and intervention, particularly during disease outbreaks, to improve patient outcomes and reduce complications.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the severe forms of sepsis affecting pregnant women in the US;
- Explain the relationship of severe forms of sepsis to rising endemic and pandemic diseases;
- Apply current treatment guidelines to manage cases of critical perinatal sepsis;
- Analyze the effectiveness of different treatment strategies for perinatal sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jason Vaught, MD
Associate Professor of Gynecology and Obstetrics
Johns Hopkins University School of Medicine
Jason Vaught, MD, is an Associate Professor of Gynecology and Obstetrics, and Surgery at the Johns Hopkins Hospital where he serves as a maternal fetal medicine and critical care specialist. His research studies and clinical expertise include maternal critical illness, cardiac disease in pregnancy, hypertensive disorders of pregnancy, and placenta accreta spectrum.
He has been active in the care of both pregnant and non-pregnant patients within the COVID pandemic. He also serves as the Director of Labor and Delivery at Johns Hopkins Hospital.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Describe the severe forms of sepsis affecting pregnant women in the US;
-
Virtual, one-day conference covering a variety of topics in antimicrobial resistance and stewardship
Description
Wednesday, April 30, 2025
According to a 2023 Sepsis Alliance survey, 85% of C-Suite executives in healthcare are concerned that antimicrobial resistance (AMR) may be increasing the potential of another pandemic. Are you ready to fight back?
Designed to explore cutting-edge solutions for antimicrobial resistance (AMR) in healthcare, the 2025 Sepsis Alliance AMR Conference provides a unique opportunity for clinicians, caregivers, patients, and the public to gain practical knowledge from experts and explore innovative approaches for combating AMR. Collaborative effort across sectors, ongoing innovation, and educational initiatives are essential to manage this intricate clinical interplay and tackle the global AMR threat.
As AMR intensifies, the risk of infections progressing to sepsis rises, leading to more challenging cases and adverse outcomes like amputations and fatalities.
We encourage you to attend sessions live, as speakers will be present to answer questions for most sessions. If you cannot attend live, sessions will be available at a later date.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this conference.
-
New!
A multi-part sepsis foundational curriculum designed to establish a strong knowledge of key sepsis concepts for nurses and other healthcare professionals
Description:
Sepsis remains the leading cause of death in U.S. hospitals. Rapid recognition and response are critical to improving sepsis survival rates. Research highlights the need for increased sepsis education among healthcare professionals, as targeted training has been shown to enhance recognition accuracy and reduce time to diagnosis across various patient populations. Sepsis Alliance Presents: Sepsis Fundamentals, a multi-part sepsis foundational curriculum designed to establish a strong knowledge of key sepsis concepts for nurses and other healthcare professionals, including sepsis coordinators, is designed to address this gap. This course serves as a foundation for more specialized sepsis training, ultimately contributing to improved patient outcomes.
Learning Objectives:
At the end of the Sepsis Fundamentals course, the learner should be able to:
- Describe the epidemiology of sepsis, including its prevalence, risk factors, and impact on patient outcomes;
- Recognize the early signs and symptoms of sepsis across different patient populations using clinical assessment tools;
- Differentiate sepsis from other conditions by interpreting diagnostic criteria, laboratory findings, and clinical presentations;
- Implement evidence-based treatment protocols for sepsis management, including fluid resuscitation, antimicrobial therapy, and supportive care;
- Support patient recovery by identifying post-sepsis syndrome symptoms and recommending appropriate follow-up care and rehabilitation strategies; Evaluate strategies for sepsis quality improvement and patient safety, including protocol adherence, early warning systems, and multidisciplinary teamwork.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges Baxter for their support for the Sepsis Fundamentals program.
-
Recorded On: 04/23/2025
Learn the latest definitions, epidemiology, diagnostic advancements, and treatment protocols for pediatric sepsis.
Description:
Date: April 23, 2025
Time: 2:00 - 3:00 pm ET
Each day, over 200 pediatric cases of severe sepsis are diagnosed in the U.S., and an average of 18 children hospitalized with sepsis die. Additionally, sepsis is missed in up to 8% of children presenting to emergency departments. During this year's Pediatric Sepsis Week (April 20-26, 2025), one of the nation’s leading sepsis experts will provide an in-depth presentation on pediatric sepsis. Dr. Zimmerman will cover the latest sepsis definitions, epidemiology, and pathophysiology for pediatrics. Learners will also explore novel diagnostic advancements, sepsis treatment bundle protocols, and long-term patient outcomes.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the contemporary definition of sepsis;
- Recall pediatric sepsis epidemiology;
- List novel sepsis diagnostic modalities;
- Summarize sepsis pathophysiology;
- Define sepsis bundled treatment protocols;
- State long-term sepsis mortality and morbidity.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jerry J. Zimmerman, MD, PhD, MCCM
Faculty, Pediatric Critical Care Medicine
Seattle Children's Hospital; Harborview Medical Center University of Washington, School of Medicine
Jerry J. Zimmerman, MD, PhD, MCCM, is a Professor of Pediatrics and Anesthesiology and a senior faculty member in the Division of Pediatric Critical Care Medicine (PCCM) at Seattle Children’s Hospital and Harborview Medical Center, University of Washington School of Medicine. A leader in pediatric critical care research, he has served on numerous national committees dedicated to advancing the field. As co-editor of Pediatric Critical Care, now in its seventh edition, he brings deep expertise in PCCM’s academic landscape.
Dr. Zimmerman has been engaged in sepsis research for over 30 years, earning international recognition for his contributions. He was an inaugural satellite site principal investigator for both the Collaborative Pediatric Critical Care Research Network (CPCCRN) and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Recently, he chaired the Society of Critical Care Medicine’s (SCCM) Discovery Research Network.
His research leadership includes serving as principal investigator for the Life After Pediatric Sepsis Evaluation (LAPSE) study (NCT01415180), which examined long-term outcomes of children with septic shock. He also led the Genotypes and Phenotypes in Pediatric SIRS and Sepsis (GAPPSS) study, evaluating the diagnostic potential of gene mRNA expression signatures (SeptiCyte™) and proteomics in distinguishing bacterial sepsis, severe viral illness, and non-infectious systemic inflammation in critically ill children.
Dr. Zimmerman played a key role in the international PODIUM collaborative, which established modern definitions for single and multiple organ dysfunctions, and led SCCM’s Taskforce in defining the Phoenix Pediatric Sepsis Definition. He is currently a co-principal investigator for the Stress Dose Hydrocortisone in Pediatric Septic Shock (SHIPSS) interventional trial (NCT03401398). A past president of SCCM, Dr. Zimmerman has been honored with distinguished service awards from both SCCM and the American Academy of Pediatrics' Critical Care Section.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Content provided by Prenosis (No CE credits offered)
Webinar Description:
Join Prenosis during this sponsored webinar to explore the impact of AI-driven diagnostics in acute care settings. Learn how FDA-authorized Sepsis ImmunoScore™ enhances traditional early warning systems by using individuals’ biology to identify patients at highest risk for sepsis, or progression to sepsis in 24 hours. Our clinical experts will discuss:
- The role of advanced biomarker analysis in improving sepsis detection and diagnosis;
- How providers can leverage AI-based technology to complement existing early warning systems and clinical decision support;
- The importance of deploying EMR-agnostic tools that integrate in existing clinical workflow;
- Use case examples illustrating the use of multi-band tests to indicate risk levels.
This sponsored webinar is ideal for healthcare professionals interested in advancing their approach to sepsis detection and management through AI-based diagnostic technology.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Prenosis for this sponsored webinar.
Robin Carver, RN, MSN, CIC
Vice President, Health System Management
Prenosis, Inc.
Robin Carver, RN, MSN, CIC, is a dynamic healthcare executive who bridges clinical care and healthcare technology, bringing over 25 years of experience in the fields of infection prevention, clinical education, and healthcare IT. Currently serving as Vice President of Health System Engagement at Prenosis, she combines her bedside nursing background with her mastery of strategic leadership to drive commercial growth and innovation in precision medicine.
As Director of Infection Prevention at WakeMed, Robin spearheaded initiatives that reduced central line infections by 87% and eliminated ventilator-associated pneumonia in the Medical ICU. Her subsequent work as VP of Member Engagement at Premier helped over 1,300 hospitals demonstrate the tangible impact of data-driven healthcare solutions and improved patient outcomes while optimizing operational efficiency.
Beyond her corporate role, Robin remains deeply committed to her local community, where she draws on her nursing expertise to help individuals and families navigate the complexities of the healthcare system. A passionate advocate for healthcare innovation, Robin combines deep clinical expertise with business acumen to help healthcare organizations navigate the evolving landscape of AI-enabled care delivery. She holds an MSN in Nursing Leadership from East Carolina University.
Jim Sianis, BS, PharmD, MBA
Executive Director, Business Development
Prenosis, Inc.
Jim Sianis, BS, PharmD, MBA, is an accomplished healthcare executive with experience spanning pharmaceutical, healthcare analytics, and diagnostic solutions. As Executive Director of Business Development at Prenosis, he leads the sales and commercialization of Sepsis ImmunoScoreTM, driving the adoption of innovative healthcare solutions grounded in data and real-world evidence.
During his 14-year tenure at Premier, Inc. Jim played a pivotal role in commercializing PINC AI's Healthcare Database, partnering with pharmaceutical, device, and diagnostic companies to create innovative solutions for unmet research needs. He also served at Merck as Medical Science Liaison supporting the anti-infective franchise, conducting high-level discussions with infectious disease thought leaders and supporting successful product launches. Jim worked as a clinical pharmacy specialist in infectious diseases at Lehigh Valley Hospital in Allentown, Pennsylvania, and served as a Hospital Corpsman and Pharmacy Technician in the United States Navy.
Jim combines deep clinical expertise with strong business acumen. His approach to business development is characterized by a strong commitment to integrity, collaboration, and strategic insight, enabling him to bridge the gap between healthcare innovation and commercial success.